After what seemed like a rally that would never end, a number of high-profile marijuana-related issuers on the TSX Venture reversed course Thursday.

Top Marijuana Stocks correct from recent highs

OrganiGram Holdings (OGI:TSXV), Canopy Growth (CGC:TSXV) and Aphria (APH:TSXV) have all had sensational runs over the past few weeks and were all declining Thursday.


OrganiGram Holdings – 5 Day Chart


Canopy Growth – 5 Day Chart


Aphria – 5 Day Chart


Liberals usher in marijuana stock rally

We first wrote about the renewed potential and optimism set to hit the marijuana space in our Weekly Volume titled Trudeau Bets $1 Billion on this Sector.

Stocks like OrganiGram and Aphria have more than doubled since this report was published. Click here to read the full report.
In our latest EBook we reveal 50 leaders who took small-cap stocks to stunning multimillion, and in some cases billion, dollar buyouts. The companies these leaders run today are also described in this one of a kind rolodex of some of the top entrepreneurs and business minds operating in North America’s small cap public markets.

Click the below image to get your free copy today. new-ebook_56

OrganiGram gives up gains after rising over 500%

OrganiGram led the decliners Thursday, falling 11.8% to $1.04 per share on nearly 5 million shares traded by 2 PM EST. OrganiGram traded to within 3 cents of its 52-week high yesterday, touching $1.42, before settling back.

OrganiGram is still up more than 5 times from its 52-week low of $0.195 – hit in early October. Venture investors have not been used to such broad moves in specific sectors.

The TSX Venture has seen its average total liquidity increase over the past few weeks. This has to be due to the resurgence in marijuana stocks as the resource sector continues to struggle. We wrote about this trend in yesterday’s Stock Challenge write up. Below is a short excerpt:

Marijuana stocks light up TSX Venture

Marijuana-related issuers on the TSX Venture have accounted for a huge percentage of the overall volume on the TSX Venture of late.

For example, on Wednesday, the TSX Venture traded a total of 61.4 million shares.

Five stocks, OrganiGram Holdings, Canopy Growth, Emerald Health Therapeutics, Maple Leaf Green World and Aphria accounted for 14.32 million shares or nearly 25% of the total volume on the exchange Wednesday.”

Click here to read the entire article, Marijuana stocks catch fire on TSX Venture.


Aphria was off 9.2% to $1.38 per share Thursday on about 1.1 million shares traded. Canopy Growth was down 9.4% on over 4.1 million shares traded.

OrganiGram, Canopy Growth and Aphria had combined to trade over 10 million shares by 2 PM EST Thursday.

Maple Leaf Green World was one of the only marijuana-related issuers in the green Thursday. It is also one of the cheapest, from a share price and market cap stand point. Its shares were up 26.32% to $0.12 per share on 2.65 million shares traded. This phenomenon of hot money flowing into smaller, less known marijuana stocks in the days and weeks after more well-known issuers, such as Canopy Growth, had made significant runs appears to be repeating itself.



This article represents solely the opinions of Alexander Smith. Alexander Smith is not an investment advisor and any reference to specific securities in the list referred to in the article does not constitute a recommendation thereof. Readers are encouraged to consult their investment advisors prior to making any investment decisions. The information in this article is of an impersonal nature and should not be construed as individualized advice or investment recommendations.

This is not an invitation to purchase any securities mentioned in this report. Pinnacle Digest does not endorse or recommend any of the referenced securities. At the time of publication and distribution of this report (12PM PST on November 5, 2015) neither, its employees or consultants owned shares in any of the mentioned companies in this report. This article is intended for informational and entertainment purposes only. The author of this article bears no liability for losses and/or damages arising from the use of this article. This report may contain technical or other inaccuracies, omissions, or typographical errors, for which and its parent company assumes no responsibility. We do not guarantee that any of the companies mentioned in this report or on will perform as we expect, and any comparisons we have made to other companies may not be valid or come into effect.

All statements in this report, other than statements of historical fact, should be considered forward-looking statements. These statements relate to future events or future performance. Much of this report is comprised of statements of projection. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. and its employees are not a registered broker-dealer or financial advisors. Before investing in any securities, you should consult with your financial advisor and a registered broker-dealer. Nothing in this article should be construed as a solicitation to buy or sell any securities. This article is intended for informational and entertainment purposes only. The author of this article bears no liability for losses and/or damages arising from the use of this article.